Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
3 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
29 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
78.3 rhumatos / 100 000 hab. — département bien doté
3 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Médecin engagé dans la recherche académique — 3 publications référencées dans les bases scientifiques internationales, contribuant aux travaux sur platelet disorders and treatments et hemophilia treatment and research.
Thématiques principales
Affiliations FR : LFB (France)
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study
2022ArticleBMC Infectious Diseases
Erratum to ‘Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae’ [International Journal of Antimicrobial Agents 49/1 67–73]
2017ArticleInternational Journal of Antimicrobial Agents
Management of haemophilia A-inhibitor patients: clinical and regulatory perspectives.
2009ArticleClinical Reviews in Allergy and Immunology
Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients
2007ArticleArthritis and Rheumatism
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP HU PSSD SITE AVICENNE
125 R DE STALINGRAD, 93009 BOBIGNY CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Arthritis and rheumatism · 2003
AbstractObjectiveTo analyze specific clinical findings, underlying disorders, treatments, outcomes, and prognostic factors for reactive hemophagocytic syndrome (RHS) in systemic disease.MethodsData were collected using standardized forms as part of a French national survey. Adult cases without an underlying malignancy, diagnosed on bone marrow or lymph node biopsy, were included.ResultsTwenty‐six cases (7 men, 19 women, mean age 47.4 ± 17.7 years) were studied. Systemic diseases included systemic lupus erythematosus (n = 14), rheumatoid arthritis (n = 2), adult onset systemic Still's disease (n = 4), polyarteritis nodosa (n = 2), mixed connective tissue disease (n = 1), pulmonary sarcoidosis (n = 1), systemic sclerosis (n = 1), and Sjögren's syndrome (n = 1). RHS occurred in 2 distinct clinical settings in the course of systemic disease. RHS was associated with an active infection in 15 patients (bacterial infections, 10 cases; viral, 3 cases; tuberculosis, 1 case; and aspergillosis, 1 case) and with the onset of a systemic disease alone in 9 cases. Isolated RHS occurred in 2 cases. The overall mortality rate was 38.5%. Two factors were associated with mortality: corticosteroid treatment at the time of RHS diagnosis, and thrombocytopenia (odds ratio = 28, 95% confidence interval = 13.3−238.9).ConclusionsWhen RHS occurs in the course of an active systemic disease (situation only reported in cases of systemic lupus or adult Still's disease), immunosuppressive therapy should be used. In contrast, when RHS is present concomitantly with an active infection, immunosuppressive therapy needs to be lowered and antibiotic therapy should be instituted.
Arthritis and rheumatism · 2007
AbstractObjectiveTo compare long and short durations of adjunctive cyclophosphamide for the treatment of severe Churg‐Strauss syndrome (CSS).MethodsIn this prospective multicenter therapeutic trial, 48 patients with CSS with at least 1 poor‐prognosis factor at baseline were treated with glucocorticoids and either 12 or 6 intravenous cyclophosphamide pulses.ResultsAt 8 years, complete remission rates and severe side effects of therapy were comparable for both groups. The overall difference in relapses was not significant between the 12‐pulse and the 6‐pulse regimens (P= 0.07), but when considering only the number of mild relapses this difference became statistically significant (P< 0.02). Although the total number of inclusions was not reached, the study was stopped prematurely in response to the superiority of the 12‐pulse regimen.ConclusionWe concluded that 12 cyclophosphamide pulses were better able to control severe CSS than a 6‐pulse regimen. The optimal duration of therapy remains to be determined.
Annals of the rheumatic diseases · 2001
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Seminars in arthritis and rheumatism · 2024 · Journal Article
Monghal V, Puéchal X, Smets P, Vandergheynst F, et al.
International journal of molecular sciences · 2023 · Journal Article
Poirot-Seynaeve X, Smets P, Pereira B, Olagne L, et al.
Annals of the rheumatic diseases · 2022 · Observational Study
Bettiol A, Urban ML, Bello F, Fiori D, et al.
Acta medica portuguesa · 2011 · Case Reports
André MC, Fraga A, Reis MD, Filipe P, et al.
Arthritis and rheumatism · 2007 · Journal Article
Cohen P, Pagnoux C, Mahr A, Arène JP, et al.
Chest · 2005 · Case Reports
Delèvaux I, Khellaf M, André M, Michel JL, et al.
Medicine · 2002 · Comparative Study
Mouthon L, Le Toumelin P, Andre MH, Gayraud M, et al.
IJU case reports · 2024 · Case Reports
André M, Macedo A, Metrogos V, Moreira L, et al.
Aging and disease · 2020 · Journal Article
Caobi A, Dutta RK, Garbinski LD, Esteban-Lopez M, et al.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians · 2011 · Journal Article
André MR, Adania CH, Allegretti SM, Machado RZ
American journal of ophthalmology · 2026 · Journal Article
Saadoun D, Ghembaza A, Touhami S, Girszyn N, et al.
Ocular immunology and inflammation · 2024 · Case Reports
Gil W, Lagrib H, Olagne L, Tilignac C, et al.
Annals of the rheumatic diseases · 2022 · Observational Study
Bettiol A, Urban ML, Bello F, Fiori D, et al.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023 · Journal Article
Dumont M, Guilhou T, Gerin M, Frémont-Goudot G, et al.
Journal francais d'ophtalmologie · 2013 · Case Reports
Bonnin N, Rousseau E, André M, Aumaître O, et al.
Journal of gastroenterology and hepatology · 2007 · Comment
André MF, Kémény JL, Aumaître O
Pediatric health, medicine and therapeutics · 2022 · Journal Article
Iversen MD, Andre M, von Heideken J
Arthritis care & research · 2015 · Clinical Study
Esbjörnsson AC, Iversen MD, André M, Hagelberg S, et al.
Lupus · 2005 · Case Reports
Delèvaux I, André M, Marroun I, Lamaison D, et al.
Annals of the rheumatic diseases · 2001 · Journal Article
Noël V, Lortholary O, Casassus P, Cohen P, et al.
Arthritis and rheumatism · 2003 · Journal Article
Dhote R, Simon J, Papo T, Detournay B, et al.
La Revue de medecine interne · 2001 · Case Reports
Delarbre X, André M, Dalens H, Delèvaux I, et al.
American journal of ophthalmology · 2026 · Journal Article
Saadoun D, Ghembaza A, Touhami S, Girszyn N, et al.
Arthritis research & therapy · 2016 · Journal Article
Smets P, Devauchelle-Pensec V, Rouzaire PO, Pereira B, et al.
International journal of rheumatology · 2012 · Journal Article
Hermet M, André M, Kémény JL, Le Guenno G, et al.
Frontiers in pediatrics · 2021 · Journal Article
Schlapbach LJ, Andre MC, Grazioli S, Schöbi N, et al.
BMJ open · 2012 · Journal Article
Carstensen J, Andersson D, André M, Engström S, et al.
Rheumatology (Oxford, England) · 2026 · Journal Article
Grobost V, Ramos M, Yelnik C, De Antonio M, et al.
Therapie · 2001 · Case Reports
Marroun I, Fialip J, Deleveaux I, André M, et al.
Clinical rheumatology · 2020 · Journal Article
Abisror N, Mekinian A, Hachulla E, Lambert M, et al.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians · 2011 · Journal Article
André MR, Adania CH, Teixeira RH, Allegretti SM, et al.